NRF2’s role in metabolic reprogramming contributes to vulvar cancer pathophysiology by driving gene expression in the pentose phosphate pathway and glutathione biosynthesis, providing cancer cells with metabolic flexibility for rapid proliferation (23). This evidence concerns the gene NFE2L2 and vulva cancer.